✦ LIBER ✦

PND5 Efficacy and Safety of Immuno-regulatory Drugs, Interferons Beta and Glatiramer in Relapsing – Remitting Multiple Sclerosis

✍ Scribed by I.M. Martínez-Férez; S. Flores-Moreno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and cost-effectiveness

✍ Boster, A.; Bartoszek, M. P.; O'Connell, C.; Pitt, D.; Racke, M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 160 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Efficacy and safety of subcutaneous inte

✍ Nicola De Stefano; Maria Pia Sormani; Bettina Stubinski; Gregg Blevins; Jelena S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 369 KB

PND13 A COST-EFFECTIVENESS ANALYSIS OF N

✍ R Gani; ER Samuels; S Hughes; G Giovanonni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-Effectiveness of Glatiramer Acetate

✍ Darba, J.; Kaskens, L.; Sánchez-de la, R.osa R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of glatiramer acetate

✍ Darbà, Josep; Kaskens, Lisette; Sánchez-de la Rosa, Rainel 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 206 KB